文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

晚发型视网膜母细胞瘤临床危险因素增加且无白瞳症:一项比较队列研究

Increased clinical risk factors and absence of leucocoria in late-onset retinoblastoma: a comparative cohort study.
PubMed 文献 · Br J Ophthalmol · 2025-11-20

这项回顾性队列研究比较了21例晚发型视网膜母细胞瘤(LoRB,≥5岁)与84例匹配的经典型(<5岁)病例,发现LoRB占全部RB的5.43%,均单眼发病且为D/E组,诊断延迟更长、白瞳症比例更低、玻璃体种植和视网膜下积液更多、眼球保留时间更短,结论强调早期识别该亚型。

要点

  • 晚发型视网膜母细胞瘤占全部RB的5.43%,诊断中位年龄80个月,均单眼发病且为D/E组。
  • 与经典型相比,晚发型诊断延迟显著更长(p=0.008),白瞳症作为首发症状的比例显著更低(p<0.001)。
  • 晚发型玻璃体种植率(p=0.03)和视网膜下积液率(p=0.04)更高,中位眼球保留时间更短(p=0.04)。

核心结论

  • 晚发型视网膜母细胞瘤具有独特的临床特征和更严重的表现,强调对该亚型早期识别和及时干预的必要性;研究结果有助于更全面理解发病年龄与RB行为的关系。

研究设计与样本

  • 回顾性队列研究,纳入2016年4月至2023年12月两家三级视网膜母细胞瘤中心诊断的21例晚发型视网膜母细胞瘤(≥5岁)和84例匹配的经典型(<5岁)病例,比较两组临床、病理和治疗结局,并按晚发型组首发症状进行亚组分析。

主要发现

  • 研究期间诊断21例晚发型视网膜母细胞瘤,占全部RB病例的5.43%,诊断中位年龄80个月,全部单眼发病且处于国际眼内视网膜母细胞瘤分类D组和E组。
  • 与对照组相比,晚发型患者诊断延迟显著更长(p=0.008),白瞳症作为首发症状的比例显著更低(p<0.001),玻璃体种植率更高(p=0.03),视网膜下积液率更高(p=0.04),中位眼球保留时间更短(p=0.04)。
  • 在晚发型组内,与具有经典型症状(白瞳症和斜视)的患者相比,具有非典型首发症状的患者诊断延迟更长(p=0.05),诊断时E组眼更多(p=0.03),中位眼球保留时间更短(p=0.05)。

临床怎么用

  • 作者认为,晚发型视网膜母细胞瘤表现更严重,有必要早期识别和及时干预该亚型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To characterise the clinicopathological features, treatment outcomes and prognostic factors in late-onset retinoblastoma (LoRB) (≥5 years) compared to classical-onset cases (<5 years). METHODS: This retrospective cohort study included 21 cases of LoRB and 84 matched classical-onset cases diagnosed between April 2016 and December 2023 at two tertiary retinoblastoma (RB) centres. Data on clinical presentations, histopathological features, treatment modalities and outcomes were collected and analysed between two groups. A subgroup analysis was performed based on presenting symptoms in the late-onset group. RESULTS: During the study period, 21 patients with LoRB were diagnosed, accounting for 5.43% of all RB cases. The median age at diagnosis was 80 months. All late-onset cases presented unilaterally and were in International Intraocular Retinoblastoma Classification groups D and E. Compared with the control group, late-onset patients demonstrated significantly longer diagnostic lag times (p=0.008), a markedly lower rate of leucocoria as the presenting symptom (p<0.001), a higher rate of vitreous seeding (p=0.03) and subretinal fluid (p=0.04), and shorter median globe salvage times (p=0.04). Late-onset patients with atypical onset symptoms experienced longer diagnostic lag times (p=0.05), more group E eyes at diagnosis (p=0.03) and shorter median globe salvage times (p=0.05) compared with those with classical symptoms (leucocoria and strabismus). CONCLUSION: LoRB presents distinct clinical features and more severe manifestations, highlighting the necessity for early recognition and timely intervention of this subtype. Our findings contribute to a more comprehensive understanding of the relationship between the age of onset and RB behaviour.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Luan Y, Xu M, Yang J, et al. Increased clinical risk factors and absence of leucocoria in late-onset retinoblastoma: a comparative cohort study. Br J Ophthalmol. 2025. PMID: 40639926. doi:10.1136/bjo-2025-327750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。